The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers
Vesprini, Danny, Narod, Steven A., Trachtenberg, John, Crook, Juanita, Jalali, Farid, Preiner, John, Sridhar, Srikala, Bristow, Robert G.Volume:
5
Journal:
Canadian Urological Association Journal
DOI:
10.5489/cuaj.619
Date:
April, 2013
File:
PDF, 117 KB
2013